EXCELYA   Report issue

For profit Phase 3 Phase 4
Founded: Boulogne France (2014)

Organization Overview

First Clinical Trial
2020
NCT04622735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Excelya | EXCELYA Bordeaux | Excelya Germany GmbH

Active Ingredients

Drugs in Phase 4 Trials (1)

tacrolimus (prograf) (1 trial)

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (1 trial)

nefopam (Acupan) (1 trial)

Drugs in Other Trials (1)

totum-854 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4